Advances in the understanding of the genetic basis of disease are leading to major developments in the diagnosis and treatment of a wide range of both common and rare disorders. Seques combines expertise in genomics with a global agency platform and extensive experience in healthcare communications. We partner with leading global pharmaceutical, biotech and diagnostic companies to create scientifically accurate and impactful programmes designed to inform healthcare professionals, patients and other stakeholder groups.
© 2019 AMICULUM Limited. All Rights Reserved. AMICULUM Limited is registered in England. Company no. 05521206